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To assess whether the absence of new thallium-2Ot up-
take after successful intracoronary thrombolysis rellects
a disturbance of myocardial cell function or lack of cap-
illary reperfusion, dual isotope scintigraphic studies with
thallium-2Ot and technetium-99m micro-albumin ag-
gregates were performed in 16 patients with acute an-
terior myocardial infarction. Intracoronary thallium-201
and technetium-99m scintigraphy performed before
intracoronary thrombolysis in 12 of the 16 patients re-
sulted in identical thallium-2Ot and technetium-99m de-
fect sizes.
Immediately after intracoronary thrombolysis, thal-
lium-201and technetium-99m scintigraphy was repeated
in 11ofthe 12 patients. In 4 of the 11, the initial thallium
and technetium scintigraphic defects were significantly
reduced, and in 6 of the 11, they were only slightly
reduced; there was no difference in the size of the re-
sidual defect as assessed with both radionuclides in all
10 of the 11 patients. In the eleventh patient, there was
After occlusion of a major epicardial coronary artery, the
ischemic myocytes enter a phase of reversible injury before
they become necrotic. During this phase, the ischemic myo-
cardium can be salvaged by reperfusion (1-3). When reflow
was allowed after 90 minutes of regional myocardial isch-
emia in dogs, portions of the inner half of the damaged
myocardium were not reperfused, as reported by Kloner et
al. (4) several years ago. Electron microscopic studies of
the nonreperfused tissue revealed severe capillary damage.
The failure to achieve uniform reperfusion after coronary
occlusion was called the "no reflow" phenomenon. Whether
this phenomenon occurs in human beings after recanaliza-
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a significant reduction of the initial technetium-99m scin-
tigraphic defect but no change in the size of the thallium-
201 defect. In four other patients, scintigrams were ob-
tained only after intracoronary thrombolysis; these re-
vealed no difference in thallium-2Ot and technetium-99m
defect size.
In seven of eight patients restudied 2 to 4 weeks after
intracoronary thrombolysis, thallium-2Ot and techne-
tium-99m defect sizes were identical with those imme-
diately after intracoronary thrombolysis; in the eighth
patient there was no difference in thallium-2Ot and tech-
netium-99m defect size, although such a difference had
been present immediately after intracoronary throm-
bolysis. These results show that the absence of new
thallium-2Ot uptake after successful intracoronary
thrombolysis rellects lack of capillary reperfusion, sug-
gesting that the "no rellow" phenomenon occurs in hu-
man beings.
(J Am Coll CardioI1985;5:593-8)
tion of a completely occluded coronary artery remains to be
established. Recently (5), we performed intracoronary thal-
lium-201 scintigraphic studies before and after intracoronary
thrombolysis and found that after reopening of the infarct
vessel, a variable amount of thallium-20l is taken up in the
ischemic area with a residual thallium-20l defect in almost
all cases.
The absence of new thallium-201 uptake after successful
intracoronary thrombolysis may reflect either a disturbance
of myocardial cell function or a lack of capillary reperfusion
despite reopening of the infarct vessel. In this study we
addressed this problem by performing intracoronary scin-
tigraphy with thallium-20l and technetium-99m micro-
albumin aggregates before and after intracoronary throm-
bolysis in patients with acute anterior myocardial infarction.
Methods
Study patients. Sixteen consecutive patients (15 men
and I woman) with a mean age of 51 years (range 37 to
79) with acute myocardial infarction due to complete oc-
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elusion of the left anterior descending coronary artery were
included in this study. The study was limited to patients
with anterior myocardial infarction because anteroseptal
scintigraphic defects and their changes are best recognized
using planar imaging. In all patients the onset of chest pain
was less than 3 hours before hospital admission and there
was ST segment elevation consistent with anterior myo-
cardial infarction with no abnormal Q waves in the leads
of ST elevation. Patients with recent gastrointestinal hem-
orrhage, peptic ulcer, trauma, stroke or malignant neoplasm
were excluded. The nature, potential benefits and possible
risks of the study were explained to the patients who gave
their written informed consent.
Protocol. Immediately after the diagnosis of acute an-
terior myocardial infarction was made, systemic intravenous
thrombolysis was performed in 4 of 16 patients. All patients
were transferred to the catheterization laboratory. The right
coronary artery was visualized first and 0.4 mCi of thallium-
201 and 0.3 mCi of technetium-99m micro-albumin aggre-
gates (15,000 particles, 15 to 20 JLm in size) were injected
into the artery. Thereafter, angiography of the left coronary
artery was performed revealing an open artery in the four
patients in whom systemic thrombolysis had been done; then
0.7 mCi of thallium-201 and 0.5 mCi of technetium-99m
micro-albumin aggregates (20,000 particles) were injected
into the left coronary artery in all 16 patients at least more
than 2 minutes after the last injection of contrast medium.
In the 12 patients with complete occlusion of the infarct
vessel, intracoronary thrombolysis was performed as pre-
viously described (6). During thrombolysis, dual isotope
scintigraphy was performed using a mobile gamma camera
(LEM Searle) connected to a mobile data acquisition system
(PDP 11-34, Gamma 11). Scintigrams were obtained with
a high resolution collimator in the 30° right anterior oblique,
30° left anterior oblique and 60° left anterior oblique views.
After recanalization, a second dose of 0.7 mCi of thallium-
201 and 0.5 mCi of technetium-99m micro-albumin aggre-
gates was injected into the infarct vessel followed by a
second series of scintigrams in the same views. In 8 of the
16 patients, angiography and dual isotope scintigraphy were
repeated 2 to 4 weeks later.
Analysis of scintigrams. The data were recorded on a
128 x 128 matrix and stored on a disk. The pictures were
flood-corrected but not smoothed. The simultaneously ob-
tained scintigrams were superimposed and then judged by
two independent observers as follows: 1) comparison of the
thallium-201 and technetium-99m defect size before throm-
bolysis; 2) comparison of the thallium-201 and technetium-
99m defect size immediately after thrombolysis; and 3) com-
parison of the thallium-201 and technetium-99m scintigrams
2 to 4 weeks after thrombolysis.
Because of the high quality of the intracoronary thallium-
201 and technetium-99m scintigrams, there was no inter-
and intraobserver variability in judging the scintigrams. In
an attempt to support the scintigraphic results obtained by
visual interpretation, the thallium-201 and technetium-99m
defect size was determined according to the following method:
a lower threshold of background activity was determined to
automatically detect the contour of the heart. An upper
threshold was determined in such a way that the automat-
ically detected defect was identical with that found visually.
Defect size was expressed as number of pixels. The same
threshold was used in each patient to determine the defect
size before and after thrombolysis.
To exclude the problem of cross talk which may be pres-
ent in dual isotope scintigraphy, in five patients intracoro-
nary thallium-201 scintigraphy was performed before and
after injection of technetium-99m into the infarct vessel.
The thallium-201 scintigrams obtained before and after tech-
netium injections were processed by the circumferential pro-
file analysis. The comparison of both quantitatively ana-
lyzed thallium-201 scintigrams (before and after technetium
injection) revealed no difference. Consequently, the unpro-
cessed scintigrams showed an identical distribution of thal-
lium-201, demonstrating that the gamma X-rays from tech-
netium-99m are not detected within the thallium-201 window
in important quantities.
Results
In all 16 patients the left anterior descending coronary
artery was reopened within 4.5 hours after the onset of
symptoms with prompt filling and good runoff of the contrast
medium.
Before thrombolysis. Scintigraphy with intracoronary
thallium-201 and technetium-99m micro-albumin aggre-
gates was performed in 12 patients before thrombolysis (Ta-
ble 1). In all 12 patients, a thallium-201 defect was found
in the anteroseptal region. The thallium defect was visually
identical with the technetium-99m defect in each patient.
These qualitatively obtained results were confirmed when
the defect size was expressed as number of pixels in the 12
patients (Table 2). The thallium-201 defect before throrn-
Table 1. Results of IntracoronaryScintigraphy With
Thallium-20l and Technetium-99m Micro-albumin Aggregates
Before and Immediately After Thrombolysis
Results before thrombolysis (12 patients)
Technetium-99m and thallium-201 defect size identical
Results immediately after thrombolysis (14 patients)
Four patients, significant reduction of the initial technetium-99 and
thallium-20I defect; defect size identical
Six patients, little reduction of the initial technetium-99m and thal-
lium-20I defect; defect size identical
One patient, significant reduction of the initial technetium-99m de-
fect, but no change of the thallium-201 defect
Three patients, no scintigraphy before thrombolysis; identical techne-
tium-99m and thallium-201 defect size after thrombolysis
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Table 2. Comparison of the Thallium-201 and Technetium -99m Defect Size Expressed in
Number of Pixels Before and Immediatel y After Thrombol ysis in 12 Patients
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Scintigraphic View
300 Left anterior oblique
600 Left anterior oblique
Radionuclide
Scintigrams
Thallium-2OJ
Technetium-99m
Thallium-20I
Technetium-99m
Defect Size
(number of pixels*)
Before Thrombol ysis After Thrombol ysis
464 1: 27I J NSt 179 1: 214J NS466 ± 236 176 ± 195
505 ± 26 1J NSt 113 ± 196J NS561 ± 301 140 ± 186
*Mean values ± standard deviation; t unpaired t test not significant (NS).
bolysis had 464 ± 217 pixels in the 30° left anterior oblique
view and 505 ± 261 pixels in the 60° left anterior oblique
view and did not differ significantly in size from the tech-
netium-99m defect (466 ± 236 and 561 ± 301 pixels,
respectively).
Studies immediately after thrombolysis. Scintigraphy
with intracoronary thallium-201 and technetium-99m micro-
albumin aggregates was performed in 14 patients immedi-
ately after thrombolysis (Table I). In four patients , a sig-
nificant reduction of the initial technetium and thallium de-
fect size was seen after thrombolysis with no difference in
the residual defect size of the two radionuclide scintigrams
(Fig. 1). In six patients only a minor reduction of the initial
technetium and thallium defect size occurred after throm-
bolysis. Again. no difference in thallium and technetium
defect size was seen (Fig. 2).
In three patients in whom no scintigrams were obtained
before thrombolysis, thallium-201 and technetium-99m
scintigraphic defect sizes after thrombolysis were visually
identical (Table 1) and did not differ significantly when
expressed as number of pixels . One patient showed a sig-
nificant reduction of the initial technetium-99m defect but
only a minor change in thallium-201 defect size after throm-
bolysis (Fig. 3).
Late studies after thrombolysis. Eight patients were
restudied 2 to 4 weeks after thrombolysis (Table 3). The
thallium-201 and technetium-99m defect sizes were iden-
tical with those immediately after thrombolysis in seven of
the eight patients. In the remaining patient , the technet ium-
99m defect size was comparable with that seen immediatel y
after thrombolysis. The thallium-20l defect, however, which
was larger immediately after thromboly sis, was now iden-
tical in size with the technetium-99m defect (Fig. 4).
Discussion
The purpose of this study was to determine whether the
residual thallium-201 defect seen in many patients after
reopening of the infarct vessel is due to lack of capillary
reperfusion or to a disturbance of myocardial thallium-20 1
uptake in the presence of adequate reperfusion. We therefore
performed dual intracoronary scintigraphy with thallium-
Figure I. Significant reduction of thal-
lium-201 (TI-20 1) and technetium-99m
micro-albumin aggregates (Tc-99m MAA)
defect size after thrombolysis with no dif-
ference in the residual defect size of both
radionuclides. LAO = left anterior
oblique.
T I - 2 0 1
before after
thrombolysis
T c - 99m MAA
before after
thro mbo lysis
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Figure 2. Minor reduction of the
thallium-20l (TI-20l) and technetium-
99m micro-albumin aggregates (Tc-
99mm MAA) defect size after throm-
bolysis with no difference in the re-
sidual defect size of both radio-
nuclides. Abbreviation as in Figure I.
before after
thrombolysis
before after
thrombolysis
201 and technetium-99m micro-albumin aggregates in pa-
tients with acute anterior myocardial infarction. We used
micro-albumin aggregates of 15 to 20 JLm in size to have
a near optimal ratio of coronary blood flow distributed to
the subendocardial and subepicardial layers of the left ven-
tricular wall (7). According to Ritchie et al. (8), two-thirds
of the total dose should be injected into the left coronary
artery and one-third into the right coronary artery at least 2
minutes after injection of the contrast medium in order to
avoid the hyperemic phase.
Perfusion defect before thrombolysis. The techne-
tium-99m perfusion defect was identical with the thallium-
201 defect in all cases when assessed visually as well as
when expressed as number of pixels. From the studies of
Reimer et al. (9), it is known that the transmural extent of
necrosis depends on the perfusion bed of the coronary artery
involved and the amount of subepicardial collateral flow.
Kolibesh et al. (l0) showed with perfusion scintigraphy that
some patients with coronary artery disease without angio-
graphically visible collateral vessels may have collateral
blood flow to the area with and without blood supply, Be-
cause of subepicardial collateral blood flow, one might have
expected the technetium-99m perfusion defect to be smaller
than the thallium-201 defect before thrombolysis, particu-
larly in patients in whom myocardium was salvaged by
thrombolysis. This, however, was not the case, either be-
cause the subepicardial collateral blood flow was too small
to be detected by planar scintigraphy or because no such
collateral blood flow existed.
Perfusion defect immediately and 2 to 4 weeks after
thrombolysis. Only in one patient was there a discrepancy
between the technetium-99m and thallium-201 scintigrams.
T I · 2 0 1 Tc ·99m MAA
Figure 3. Significant reduction of the
technetium-99m micro-albumin aggre-
gates (Tc-99m MAA) defect size after
thrombolysis, but only minor change in
the thallium-20l (TI-201) defect size after
thrombolysis. Abbreviation as inFigure I.
before immediate ly aft er
thrombo ly sis
before immediately afte r
thrombolysis
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Table 3. Results of Intracoronary Scintigraphy with Thallium-
201 and Technetium-99m Micro-albumin Aggregates 2 to 4
Weeks After Thrombolysis in Eight Patients
Seven patients, technetium-99m and thallium-201 defect size identical to
that immediately after thrombolysis
One patient, technetium-99m defect size identical to that immediately
after thrombolysis; thallium-201 defect size now identical to that of
technetium-99m defect size
According to the technetium-99m scintigram, the antero-
septal region was reperfused, but there was no thallium-20l
uptake in this area. In the remaining patients, no difference
was found, either visually or when expressed as number of
pixels, between technetium-99m and thallium-20l defect
sizes immediately after thrombolysis or 2 to 4 weeks later.
The patient mentioned showed new thallium-20l uptake 3
weeks after thrombolysis in the same region that was re-
perfused immediately after thrombolysis but did not show
significant thallium-201 uptake initially.
Thallium uptake versus regional myocardial flowand
myocardial viability. This difference between the two
radionuclide scintigrams immediately after thrombolysis
suggests that new thallium-20l uptake depends not only on
the restoration of capillary flow, but also on the functional
integrity of the myocytes. We cannot exclude, however, the
possibility that this difference is due to a difference in eryth-
rocyte flow reflected by technetium-99m micro-albumin ag-
gregates and plasma flow reflected by thallium-20l (11).
Melin et a1. (12) experimentally showed differences in thal-
lium-20l uptake in reperfused myocardial infarction. Al-
though they found close correlation between thallium-20l
uptake and regional myocardial blood flow in nonreperfused
animals, in reperfused animals thallium-20I uptake was re-
duced disproportionately to blood flow. In one of our patients,
T I · 2 0 '
this discrepancy between myocardial thallium-20l uptake
and flow was only evident immediately after thrombolysis.
Small differences in thallium-201 and technetium-99m de-
fect size, however, could have been missed in our study
because the resolution of planar scintigraphy is limited.
In a more recent study in dogs, Okada and Pohost (13)
evaluated the use of preintervention and postintervention
thallium-201 imaging for assessing the effects of experi-
mental coronary artery reperfusion. They concluded that
at 10 minutes and I hour after reperfusion, thallium-20l
uptake is more related to flow than to myocardial viability,
thereby leading to thallium-20l uptake in necrotic zones,
whereas the results of thallium-20l imaging 48 hours after
reperfusion correlate with the presence or absence of myo-
cardial infarction.
"No reflow" after reperfusion of ischemic myocar-
dium. Except for the one patient mentioned earlier, all pa-
tients had a defect in the thallium-20l scintigram after
thrombolysis that was identical in size with the residual
technetium-99m scintigraphic defect. This finding is in
agreement with the data of Okada and Pohost (13). In our
study, however, there was no difference between the thal-
lium-20l and technetium-99m defect size immediately after
thrombolysis and that found 2 to 4 weeks later except in
one patient, in whom an early thallium-201 defect became
smaller at follow-up. Again, in contrast to Okada and Pohost
(13) who found a correlation between new thallium-20l
uptake and myocardial viability only 48 hours after reper-
fusion, we showed in a previous clinical study (5) an im-
provement in regional wall motion in the area of immediate
new thallium-20l uptake in patients with acute myocardial
infarction undergoing intracoronary thrombolysis, In the
presence of a normal filling and runoff of the contrast me-
dium in the epicardial infarct vessel, a residual technetium-
99m perfusion defect reflects the area of "no reflow. " The
Tc ·99m MAA
Figure 4. Comparison of the thallium-
201 (TI-20l) and technetium-99m mi-
cro-albumin aggregates (Tc-99m MAA)
scintigrams obtained immediately and 3
weeks after thrombolysis. See text for
details. Abbreviation as in Figure 1.
immedia te ly 3 weeks
aft er thrombolysis
LAO : 30
, I " .... .::
t . -"• ~
-..,A'I:,.
.!
LAO 60°i\ .
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I '
immed iately 3 weeks
after thrombolysis
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size of this area of "no reflow" was not significantly dif-
ferent from that before thrombolysis in about half of the
patients, indicating that reperfusion did not take place in
the whole acutely ischemic segment.
Microvascular damage versus myocardial cell necro-
sis. The question whether microvascular damage or necro-
sis of myocardial cells comes first after coronary artery
occlusion is answered in the dog model (14), but not in
human beings. Kloner et al. (14) could not find ultrastruc-
tural evidence of myocardial vascular damage without myo-
cardial cell injury, suggesting that ultrastructural myocardial
vascular damage is not the primary cause of irreversible
myocardial cell injury. Additional evidence of microvas-
cular cell damage is the hemorrhagic infarction after reper-
fusion of the infarct area (14,15). Autopsy studies in human
beings of hemorrhagic infarction after coronary artery re-
perfusion revealed that the hemorrhage exclusively occurs
within the area of myocardial cell necrosis (16), supporting
the hypothesis that the "no reflow" phenomenon in human
beings is not the cause of myocardial necrosis but rather its
consequence.
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